Stockreport

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

TransCode Therapeutics, Inc.  (RNAZ) 
PDF BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effec [Read more]